INTRODUCTION
The olfactory bulb (OB) is located bilaterally above the cribriform plate of the anterior cranium base. It is the first relay station in the olfactory pathway before any thalamic connection [1] [2] [3] . The OB gathers sensory afferents of olfactory receptor cells situated in the olfactory neuroepithelium, and it ends with the olfactory tract (OT) [4] [5] [6] . Clinically, the OB has raised scientific interest during the last years for many reasons; it is one of the few areas in the brain, at least in animals, where adult neurogenesis continuously occurs 7 . The OB plays a pivotal role in processing olfactory information and receives input from sensory neurons located in the olfactory epithelium that respond to odors 8 . There is some evidence that olfactory deficits are linked to structural and/or functional changes at the level of the OB 9 , leading to the possibility of using OB volumetry as a prognostic tool to assess the course of olfactory loss. Olfactory loss may be secondary to various diseases, such as sinonasal disease, infections of the upper respiratory tract, h e a d t r a u m a , a n d n e u r o d e g e n e r a t i v e diseases 10, 11 . Thus far, research into cognitive dysfunction in psychiatric disorders has focused primarily on processes supported by visual or auditory inputs, and cognitive functions that are connected to olfactory stimuli have been relatively neglected 12 . In recent years, some studies have focused on olfactory dysfunction in different neuropsychiatric disorders 13 . These studies suggested that the olfactory system should be investigated as a potential biomarker to identify patients early in the course of illness. The olfactory system may be of particular utility in schizophrenia and in understanding neurodevelopmental processes, given that it remains plastic throughout lifetime 14 . Olfactory defects have been identified in schizophrenia; however, the existence of olfactory deficits in mood disorders is equivocal 15 . Major depression is representative of this uncertainty, with results covering nearly the whole spectrum of olfactory testing outcomes 16 . Developments in structural and functional neuroimaging techniques emphasize the potential neuroanatomical substrates of psychiatric disorders 17 . Due to the continuous development of magnetic resonance imaging (MRI) techniques, MRI-based volumetric analyses represent an ideal instrument with which to evaluate OB volume, which seems to represent the functional condition of the olfactory system 18 . The aim of this study was to evaluate the effect of chronic major depression (lasting at least 2 years) on OB volumes in a series of patients with chronic major depression treated with a selective serotonin reuptake inhibitor (SSRI). To the best of our knowledge, this is the first study to investigate this subject. In this study, we document structural changes in the olfactory bulbs of the brain in chronic major depression.
METHODS

Participants
All participants provided written informed consent to participate in the study in accordance with the Declaration of Helsinki, and the study was approved by the Institutional Review Board. The study was also approved by the Local Clinical Research Ethics Committee (appl. no: 138).
Thirty-one patients with chronic depression who were admitted to the psychiatry clinic of the State Hospital and University School of Medicine, between March 1 and August 31, 2013 comprised the study group. Specifically, patients with chronic depression (>2 years) who were medicated with only SSRIs and who visited the psychiatry outpatient clinic for routine control examinations were studied. The sample consisted of 31 patients (17 females and 14 males) aged 38.5±11.14 years (mean±SD) with an age range of 20-59 years. All patients were receiving treatment with a single SSRI. Depression duration was 5.09±2.56 years. The control group included 16 females and 15 males with a mean age of 38.96±10.67 years and an age range of 21-55 years. The control group consisted of voluntary participants who had been admitted to the hospital with various complaints between March 2013 and August 2013. They were free from organic and neurological disorders according to diagnostic coronal MRI. Exclusion criteria related to depression were applied to the control group. All participants were recruited by phone after the study design was finalized.
The Beck Depression Inventory (BDI) was administered to all participants. A diagnosis of chronic depression was made according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). After providing a complete history and undergoing a general medical examination, all participants received a complete otolaryngological examination to exclude any nasal pathology that might concomitantly cause olfactory dysfunction. Other exclusion criteria included the presence of acute or chronic neurological, medical, and/or other psychiatric illnesses; alcohol and/or drug abuse; and being older than 65 or younger than 18 years.
BDI
The BDI is a self-report inventory that evaluates risk factors for depression and the severity of depressive symptoms. It consists of 20 items rated on four Likert-type scales and can be used with both healthy and patient groups. Every item is scored from 0 to 3, and the total score, which ranges from 0 to 63, is the sum of all item scores. The cut-off score for validity and reliability in the Turkish version of the scale is 17. The scale was originally developed by Beck 19 and adapted for Turkish populations by Hisli et al. 20 .
MRI
All investigations were performed using a 1.5-Tesla MRI system. Volumes of the right and left OB were calculated using MRI scans of the head and a standardized protocol for OB examination. A characteristic protocol included: (a) 5-mm-thick standard T2-weighted fast spin-echo images covering the entire brain without interslice space to rule out any organic brain disorder; and (b) 2-mm-thick T1-and T2-weighted fast spin-echo images without interslice space in the coronal plane covering the anterior and middle segments of the skull base ( Figure OB) . OB contours were delineated using an electronic cursor on all images where an OB was present. For every segment, the surface of the contoured region was computed in mm 2 . Whole segment regions were added and multiplied by two for the 2-mm slice thickness to obtain a volume in mm 3 , as reported in previous studies 4, 5 .
Statistical Analyses
Statistical analyses were performed using SPSS software 18.0 (SPSS Inc., Chicago, IL, USA). Descriptive analyses are presented in terms of means and standard devations (SDs) for normally distributed variables. As the depression scores and OB volumes were normally distributed, Student's t-tests were used to compare these parameters between patient and control groups. Correlation coefficients and significance were calculated with Pearson's test in patients with depression. Results with a p value <0.05 were considered statistically significant.
RESULTS
The depressed patients group included 31 patients (17 female, 14 male) with chronic major depressive disorder (MDD) with a mean age of 38.51±11.54 years. The mean BDI scores of depressed and control groups were 30.74±10.14 and 6.38±3.02, respectively. The control group consisted of 31 subjects (16 female and 15 male) Table 1. OB volumes were calculated separately for the depressed patients and the control groups. In the depressed patients group, the mean right OB volume was 61.41±10.75 mm 3 with a volume range of 42.40-85.70 mm 3 ( Figure 1) Figure 2 ). We found a statistically significant difference in OB volume between the depressed patients and the control group (t=-3.43 and p<0.01 for right OB, t=-3.54 and p<0.01 for left OB, Table 2 ). We also found a strong negative correlation between BDI depression scores and OB volume (right: r=-0.727 and p<0.01, left: r=-0.717 and p<0.001, 
DISCUSSION
In this study, we found a statistically significant difference in OB volume between the depressed patients and the control group. OB volumes were smaller in depressed patients than the control group. We also found a strong negative correlation between BDI depression scores and OB volumes. Studies on olfactory perception in individuals with chronic depression demonstrate that patients principally demonstrate a deficit in the hedonic aspects of smell; in some cases, alterations in sensitivity or identification may also exist 21 . Pollatos et al. 22 studied olfactory sensitivity in healthy subjects with depressive symptoms and detected a significant negative correlation between olfactory sensitivity and depressive symptoms. A correlation between olfactory function and depression scores was reported in previous studies 23 . Neurogenesis in the hippocampal formation is suppressed due to several factors, such as extended stress, that may predispose individuals to major depressive disorder. In these cases, the rationale behind treatment is based on attempting to reverse these factors via antidepressant treatment 24 . Clinical interest in the OB has recently increased due to the idea that olfactory function is reflected in OB volume 25 . Thus, OB size has been investigated in various clinical conditions, including post-infectious olfactory deficits, posttraumatic chemosensory deficits, congenital anosmia, sinonasal disease, neurodegenerative disorders, multiple sclerosis, and psychiatric disorders, as well as in subjects with a normal sense of smell 26 . Recently, this interest in the olfactory system as it relates to schizophrenia has produced a number of findings. Turetsky et al. 27 demonstrated a statistically significant bilateral volume decrease in the olfactory bulb of patients with schizophrenia. Reduced olfactory sensitivity in major depressive disorder was replicated in another study 28 . Few investigations found olfactory dysfunction in patients with multiple sclerosis (MS). Volumetric calculations of the OB were performed by manual segmentation in 36 MS patients in a recent study. There was a positive correlation between volumetry of the OB and olfactory function in patients with a decreased OB volume in this study 29 . Antidepressants are known to impact gustatory function, but there is no evidence of quantitative olfactory impairment in humans 30 . In another study, twenty treatment-free premenopausal women diagnosed with longterm, severe MDD, volumetric calculations of the OB were performed by manual segmentation according to a standardized protocol, and results showed that the OB volume gets larger in longterm MDD 31 . In another study conducted with animals, OB cauterization was applied to twenty rats and mechanical olfactory bulbectomy was applied to ten rats. All of the rats in the study groups, particularly in the cauterization group, showed symptoms similar to depression 32 . Similar results were found in another animal study 33 . Several animal investigations suggest that SSRIs might impact olfactory function; citalopram and clomipramine induce a reduction in olfactory sensitivity in mice after 3 weeks of treatment 34 . Despite these important findings, the exact role of chronic MDD and SSRIs in the etiology of OB volume reduction remains unclear.
In conclusion, our results reflect a statistically significant bilateral OB volume reduction in patients with chronic major depression treated with a single SSRI as compared to a non-depressed control group. One of the main limitations of this study is the lack of olfactory test results. Additionally, BDI scores were strongly negatively correlated with OB volume (Table 3) . Our study highlights a significant reduction in the OB volumes of patients with chronic major depression.
The possibility that this finding may reflect a chronic impact of medication cannot be ruled out by this study. To clarify this issue, additional comparative studies on patients with chronic depression undergoing different treatment regimens are needed.
